CA Patent

CA2692923A1 — Intraoperative imaging methods

Assigned to Beth Israel Deaconess Medical Center Inc · Expires 2008-06-26 · 18y expired

What this patent protects

Described are methods for intraoperative imaging of anatomical structures using fluorescent compounds, e.g., compounds that fluoresce in the invisible light (IL) region of the spectrum, i.e., above 670 nm. An exemplary compound is methylene blue.

USPTO Abstract

Described are methods for intraoperative imaging of anatomical structures using fluorescent compounds, e.g., compounds that fluoresce in the invisible light (IL) region of the spectrum, i.e., above 670 nm. An exemplary compound is methylene blue.

Drugs covered by this patent

Patent Metadata

Patent number
CA2692923A1
Jurisdiction
CA
Classification
Expires
2008-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Beth Israel Deaconess Medical Center Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.